Clinical Trials Directory

Trials / Unknown

UnknownNCT05535842

Diabetes Companion App for Adults With Diabetes and Their Carers

Conversational Agent for Supporting People With Type 2 Diabetes and Their Carers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
224 (estimated)
Sponsor
Nanyang Technological University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Diabetes self-management support, education, and training are increasingly being delivered through digital technology such as mobile phones. This protocol aims to evaluate the effectiveness of GLOW, a diabetes companion app with a conversational agent.

Detailed description

Adopting a healthier lifestyle and disease self-management skills is critical to reducing the risk of diabetes-related complications. Internationally, and in Singapore, the majority of people with diabetes report not having received structured diabetes education, while others have the knowledge and fail to apply it in their daily lives. Key self-management behaviours recommended by the American Association of Diabetes Educators include physical activity, healthy diet, blood glucose monitoring, and medication adherence, but equally important is healthy coping to maintain a positive attitude toward diabetes management. Life-long patient education and continuous empowerment are paramount to successful self-management in people with diabetes, as recommended by evidence-based diabetes management guidelines. In addition to patients, their informal carers often play an important role in the management of diabetes. As such, diabetes education for informal carers is essential to achieve the best possible diabetes outcomes in the patient. There are hundreds of diabetes apps available for the public to download and use, but few are rigorously evaluated for clinically meaningful outcomes. We designed GLOW, a diabetes companion app with a conversational agent, to support people with diabetes and their carers with self-management and knowledge.

Conditions

Interventions

TypeNameDescription
OTHERGLOWGLOW is an app for type 2 diabetes support and education that uses a conversational agent to help users develop self-management skills and learn about diabetes and healthy behaviours. This is achieved through a range of interactive strategies.

Timeline

Start date
2022-11-28
Primary completion
2023-08-31
Completion
2023-09-30
First posted
2022-09-10
Last updated
2023-03-27

Locations

2 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05535842. Inclusion in this directory is not an endorsement.